GB1227978A - - Google Patents
Info
- Publication number
- GB1227978A GB1227978A GB1227978DA GB1227978A GB 1227978 A GB1227978 A GB 1227978A GB 1227978D A GB1227978D A GB 1227978DA GB 1227978 A GB1227978 A GB 1227978A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- methyl
- general formula
- reaction
- phenoxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006243 chemical reaction Methods 0.000 abstract 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 5
- -1 benzyloxycarbonylmethyl Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000006678 phenoxycarbonyl group Chemical group 0.000 abstract 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 abstract 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- VEUMBMHMMCOFAG-UHFFFAOYSA-N 2,3-dihydrooxadiazole Chemical compound N1NC=CO1 VEUMBMHMMCOFAG-UHFFFAOYSA-N 0.000 abstract 2
- 125000005079 alkoxycarbonylmethyl group Chemical group 0.000 abstract 2
- 230000018044 dehydration Effects 0.000 abstract 2
- 238000006297 dehydration reaction Methods 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000004867 thiadiazoles Chemical class 0.000 abstract 2
- VQJMFXJFKFPGAL-UHFFFAOYSA-N 2-[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)C1=NC(=NO1)CC(=O)N VQJMFXJFKFPGAL-UHFFFAOYSA-N 0.000 abstract 1
- QBGONPQFBDUVPG-UHFFFAOYSA-N 4-chloro-n'-hydroxybenzenecarboximidamide Chemical compound ON=C(N)C1=CC=C(Cl)C=C1 QBGONPQFBDUVPG-UHFFFAOYSA-N 0.000 abstract 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 150000004703 alkoxides Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 abstract 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 150000004678 hydrides Chemical class 0.000 abstract 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 abstract 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- TXBYGOVGEZWDPT-UHFFFAOYSA-N methyl 2-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]acetate Chemical compound O1C(CC(=O)OC)=NC(C=2C=CC(Cl)=CC=2)=N1 TXBYGOVGEZWDPT-UHFFFAOYSA-N 0.000 abstract 1
- VHICHLFMVPHOJW-UHFFFAOYSA-N methyl 2-[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]acetate Chemical compound ClC1=CC=C(C=C1)C1=NC(=NO1)CC(=O)OC VHICHLFMVPHOJW-UHFFFAOYSA-N 0.000 abstract 1
- 229940102396 methyl bromide Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4362868 | 1968-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1227978A true GB1227978A (enrdf_load_stackoverflow) | 1971-04-15 |
Family
ID=10429626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1227978D Expired GB1227978A (enrdf_load_stackoverflow) | 1968-09-13 | 1968-09-13 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE738831A (enrdf_load_stackoverflow) |
| DE (1) | DE1946638A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2018062B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1227978A (enrdf_load_stackoverflow) |
| NL (1) | NL6913673A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4618617A (en) * | 1982-03-03 | 1986-10-21 | Sumitomo Chemical Company, Limited | Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof |
| JPWO2021187486A1 (enrdf_load_stackoverflow) * | 2020-03-17 | 2021-09-23 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4562186A (en) * | 1985-01-22 | 1985-12-31 | Hoechst-Roussel Pharmaceuticals Inc. | (1,2,4-Oxadiazol-3-yl)arylmethanones, compositions and pharmaceutical use |
| AU736026B2 (en) * | 1997-12-17 | 2001-07-26 | Merck & Co., Inc. | Integrin receptor antagonists |
-
1968
- 1968-09-13 GB GB1227978D patent/GB1227978A/en not_active Expired
-
1969
- 1969-09-09 NL NL6913673A patent/NL6913673A/xx unknown
- 1969-09-12 BE BE738831D patent/BE738831A/xx unknown
- 1969-09-12 FR FR6931141A patent/FR2018062B1/fr not_active Expired
- 1969-09-15 DE DE19691946638 patent/DE1946638A1/de active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4618617A (en) * | 1982-03-03 | 1986-10-21 | Sumitomo Chemical Company, Limited | Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof |
| JPWO2021187486A1 (enrdf_load_stackoverflow) * | 2020-03-17 | 2021-09-23 | ||
| US20230265061A1 (en) * | 2020-03-17 | 2023-08-24 | Sumitomo Pharma Co., Ltd. | Oxadiazole derivative |
| JP7637121B2 (ja) | 2020-03-17 | 2025-02-27 | 住友ファーマ株式会社 | オキサジアゾール誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| NL6913673A (enrdf_load_stackoverflow) | 1970-03-17 |
| FR2018062A1 (enrdf_load_stackoverflow) | 1970-05-29 |
| BE738831A (enrdf_load_stackoverflow) | 1970-03-12 |
| DE1946638A1 (de) | 1970-09-03 |
| FR2018062B1 (enrdf_load_stackoverflow) | 1974-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1140748A (en) | New carboxylic acid derivatives | |
| ES467890A1 (es) | Procedimiento para preparar acido di-n-propilacetico. | |
| SE7506327L (sv) | Forfarande for framstellning av 8-tiometylergoliner | |
| GB1250719A (enrdf_load_stackoverflow) | ||
| GB1227978A (enrdf_load_stackoverflow) | ||
| GB1382513A (en) | 1-pyridylalkyl-indole derivatives | |
| GB1334705A (en) | Pharmaceutical compositions containing kynurenic acid derivatives | |
| US3669987A (en) | Salts of indole derivatives and a process for preparing the same | |
| IE44014L (en) | Amino-benzocycloheptenes. | |
| ES421068A1 (es) | Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas. | |
| NL7502807A (nl) | Nieuwe ergoleen en ergolinederivaten en werk- wijze voor de bereiding daarvan. | |
| ES422472A1 (es) | Procedimiento para preparar 2- (fenoxialquiltio) imidazo- les. | |
| GB1365173A (en) | Cyclopentane derivatives | |
| IE792508L (en) | Piperidylindoles | |
| GB1139940A (en) | Oxazole derivatives | |
| KR890009879A (ko) | 5- 아미노-1- 페닐-4-니트로피라졸의 제조방법 | |
| GB1088295A (en) | Derivatives of alkanoic acids and methods for their preparation | |
| GB1409633A (en) | Process for preparing primary 3-carbamoyloxy-methyl cephalosporins | |
| GB1118867A (en) | Phenoxazine derivatives | |
| ES426951A1 (es) | Procedimiento para la preparacion de nuevos esteres de aci-dos carboxilicos de 3-(4-bifenilil)-alcanoles. | |
| GB1226981A (enrdf_load_stackoverflow) | ||
| GB1099209A (en) | 5-sulfamoylanthranilic acid derivatives | |
| GB1220599A (en) | New furazan derivatives, processes for their production and compositions containing them | |
| ES442068A1 (es) | Procedimiento para la preparacion de nuevos derivados de bi-fenilo. | |
| SE7705257L (sv) | Sett for framstellning av acetonitrilderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |